JPMORGAN CHASE & CO - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 48 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$12,328,000
+80.4%
4,638,000
+23.7%
0.00%
+50.0%
Q4 2014$6,833,000
-70.9%
3,748,000
-61.3%
0.00%
-66.7%
Q3 2014$23,443,000
-0.3%
9,692,000
-19.0%
0.01%0.0%
Q2 2014$23,503,000
+157.9%
11,972,000
+122.2%
0.01%
+100.0%
Q1 2014$9,112,000
-53.9%
5,389,000
-59.4%
0.00%
-50.0%
Q4 2013$19,780,000
+3.8%
13,270,000
-14.6%
0.01%0.0%
Q3 2013$19,059,000
-1.6%
15,535,000
-4.3%
0.01%0.0%
Q2 2013$19,362,00016,228,0000.01%
Other shareholders

There were no reported owners of SALIX PHARMACEUTICALS INC in Q3 2013.

NameSharesValueWeighting ↓
View complete list of SALIX PHARMACEUTICALS INC shareholders